| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/14/2008 | EP1921064A1 Pharmaceutical composition |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1919909A2 Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
| 05/14/2008 | EP1723114B1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 05/14/2008 | CN101180296A Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors |
| 05/14/2008 | CN101180288A Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs |
| 05/14/2008 | CN100387579C Graftable hindered amine light stabilizers |
| 05/13/2008 | US7371867 Non-racemic trifluoroleucine, and methods of making and using |
| 05/13/2008 | US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/08/2008 | WO2008054290A1 1h-pyridine- 2 -one derivatives useful in treatment of pai-1 related disorders |
| 05/08/2008 | WO2008054096A1 Crystalline s-(-)-amlodipine adipic acid salt anhydrous and preparation method thereof |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053352A2 Phenylpropionamide compounds and the use thereof |
| 05/08/2008 | WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | WO2008052769A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/08/2008 | WO2008024371A3 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 05/08/2008 | WO2008010953A3 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 05/08/2008 | US20080108825 Compounds for treatment of inflammation, diabetes and related disorders |
| 05/08/2008 | US20080108824 Has a bioactive ( being less soluble in water when the proton binding site is in the non-ionic form than when the proton binding site is in the ionic form) and having a desired rate of bioactive release |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108667 [(5,6-dichloropyridin-3-yl)methyl](methyl)-oxido lambda 4-sulfanylidenecyanamide; Insecticides; potentiation; atypical mode of action; effective control in agricultural, urban and/or animal health systems by applying to a locus; control of foliar-feeding insects; aphids and other sucking insects |
| 05/08/2008 | US20080108663 Cyclopropyl Piperidine Glycine Transporter Inhibitors |
| 05/08/2008 | US20080108662 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108618 Compounds with activity on muscarinic receptors |
| 05/08/2008 | US20080108594 Antithrombotic Ethers |
| 05/08/2008 | CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | CA2666750A1 Phenylpropionamide compounds and the use thereof |
| 05/07/2008 | EP1918281A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/07/2008 | EP1918280A1 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide and salts thereof |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1722795B1 Piperidinyl prostaglandin e analogs |
| 05/07/2008 | EP1641729B1 Use of functionalized onium salts as a soluble support for organic synthesis |
| 05/07/2008 | EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 05/07/2008 | CN101175726A Process for the preparation of opioid modulators |
| 05/07/2008 | CN101175725A Process for the preparation of opioid modulators |
| 05/07/2008 | CN101172965A Piperidine ester compounds for producing catalyst for polymerization of olefins and catalyst thereof |
| 05/07/2008 | CN101172964A 3-(4-piperidine group) substituted tetrahydronaphthalene derivative compounds and synthesis method thereof |
| 05/07/2008 | CN100386313C Novel herbicides |
| 05/06/2008 | US7368568 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use |
| 05/06/2008 | US7368462 4'-Fluoro-biphenyl-4-carboxylic acid (6-dimethylaminomethyl-naphthalen-1-ylmethyl)-amide; obesity; side effects reduction; selective binding; no stimulation of the central nervous system and no peripheral activity caused by activation of 5-HT2c receptors; improved cellular potency and pharmacokinetics |
| 05/06/2008 | US7368461 Compounds and method for the treatment of overactive bladder |
| 05/06/2008 | US7368443 Central nervous system disorders, drug abuse, obesity |
| 05/02/2008 | WO2008051875A2 Adamantylurea compounds as soluble epoxide hydrolase inhibitors |
| 05/02/2008 | WO2008051873A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 05/02/2008 | WO2008051056A1 Method for the separation of s-(-)-amlodipine from racemic amlodipine |
| 05/02/2008 | WO2008050857A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 05/02/2008 | WO2008050351A1 NOVEL POLYMORPHIC FORMS OF l-BENZYL-4-[(5,6-DIMETHOXY-l-INDANONE)-2-YL]METHYL PIPERIDINE [DONEPEZIL] AND PROCESS FOR PREPARING THE SAME |
| 05/02/2008 | WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008049806A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/02/2008 | CA2666482A1 Soluble epoxide hydrolase inhibitors |
| 05/02/2008 | CA2664141A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/01/2008 | US20080103311 Retroviral protease inhibitors |
| 05/01/2008 | US20080103302 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer |
| 05/01/2008 | US20080103229 Curable acrylic mixture including a hindered amine light stabilizer having a 4-Amino-2,2,6,6-tetramethylpiperidin-1 oxyl moiety linked to an acrylic moiety so as to polymerize with the primary resin |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103176 N-{1-(3,5-Difluoro-benzyl)-3-[7-(2,2-dimethyl-propyl)-2-piperidin-1-yl-1,2,3,4-tetrahydro-naphthalen-1-ylamino]-2-hydroxy-propyl}-acetamide; 13-secretase inhibitor; Alzheimer's disease; inhibitors of beta-secretase, that inhibit beta-secretase-mediated cleavage of amiloid precursor protein APP |
| 05/01/2008 | US20080103139 3-Carbamoyl-2-Pyridone Derivative |
| 05/01/2008 | US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 05/01/2008 | US20080103123 4-phenyl-3-substituted pyridin compounds such as tert-Butyl 4-[({5-[4-(methylsulfonyl)phenyl]pyridin-2-yl}oxy)methyl]-piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 05/01/2008 | US20080103049 Benzoyl-Substituted Serineamides |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 04/30/2008 | EP1916527A1 Analysis of mass spectral data in the quiet zones |
| 04/30/2008 | EP1915996A1 Agents for treating intraocular inflammation caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 04/30/2008 | EP1915342A1 A novel hydroxamic acid derivative as peptide deformylase inhibitor and manufacturing method thereof |
| 04/30/2008 | CN101171248A 3-mono- and 3,5-disubstituted piperidine derivatives as renin inhibitors |
| 04/30/2008 | CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 04/30/2008 | CN101168527A Undecane to pentadecane dicarboxylic acid di(2,2,6,6-tetramethylpiperidinyl)ester and use thereof |
| 04/30/2008 | CN100384826C Preparation of sterically hindered amine ethers |
| 04/30/2008 | CN100384822C 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/30/2008 | CN100384421C N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365082 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008046918A2 Addition reactions using transition metal catalysts in halogenated solvents |
| 04/24/2008 | WO2008046889A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents |
| 04/24/2008 | WO2008046573A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097099 Insecticides; for human or veterinary medicine; preparing heterocyclic amide and imine derivatives |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia |
| 04/24/2008 | US20080096898 Organic Compounds |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096867 Imidazo[1,2-A] Pyridine Anxiolytics |
| 04/24/2008 | US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis |
| 04/24/2008 | US20080095708 Biphenyl compounds useful as muscarinic receptor antagonists |